Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study
This study was funded by the Spanish Ministry of Science and Innovation (SAF 2012-31017, Principal Investigator C.S.), Spanish Ministry of Health (EC11-299, Principal Investigator C.S.) and Regional Valencian Ministry of Education (PROMETEOII/2013/018, Principal Investigator C.S.). Four authors (X.S., I.C., A.P. and C.S.) are co-inventors of the patent resulting from this work (Application number: 62/013,121). S.C., C.A., F.R., J.F., J.P. and J.R. have no conflict of interest in relation to this work.
TRIAL REGISTRATION NUMBER
This study was registered with ClinicalTrials.gov (NCT02144987).
Source: Human Reproduction - Category: Reproduction Medicine Authors: Santamaria, X., Cabanillas, S., Cervello, I., Arbona, C., Raga, F., Ferro, J., Palmero, J., Remohi, J., Pellicer, A., Simon, C. Tags: Reproductive biology Source Type: research
More News: Asherman's Syndrome | Babies | Biology | Education | Funding | Health | Hormones | Hospitals | Hysteroscopy | Infertility | Men | Miscarriage | Pregnancy | Reproduction Medicine | Science | Stem Cell Therapy | Stem Cells | Study | Ultrasound | Universities & Medical Training